1.73
0.58%
0.01
Handel nachbörslich:
1.73
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.04%
41.77
|
50.35 | 57.95 | 57.15 | 42.55 |
Operating Income/Loss |
17.04%
-41.77
|
-50.35 | -57.95 | -57.15 | -42.55 |
Nonoperating Income/Loss |
11.05%
3.196
|
3.593 | 3.924 | 3.894 | 3.621 |
Income/Loss From Continuing Operations Before Tax |
17.44%
-38.57
|
-46.72 | -54.03 | -53.25 | -38.93 |
Income/Loss From Continuing Operations After Tax |
17.44%
-38.57
|
-46.72 | -54.03 | -53.25 | -38.93 |
Net Income/Loss
|
17.50%
-38.57
|
-46.75 | -54.03 | -53.25 | -38.93 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
34,288%
61.83
|
0.1798 | 58.88 | 58.56 | 57.64 |
Diluted Average Shares |
34,288%
61.83
|
0.1798 | 58.88 | 58.56 | 57.64 |
Basic Earnings Per Share |
21.52%
-0.62
|
-0.79 | -0.92 | -0.91 | -0.68 |
Diluted Earnings Per Share |
21.52%
-0.62
|
-0.79 | -0.92 | -0.91 | -0.68 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):